Psychosis

In a First Episode of Psychosis (FEP), Distinct Symptoms, Cognition, and EEG Measures Seen in Cannabis Users vs. Non-Users

A team led by a two-time BBRF grantee has published research suggesting the possibility that cannabis use in some individuals may be associated with a distinct subtype of first-episode psychosis (FEP… Read More

In Youths at High Risk of Psychosis, a Marker in White Blood Cells May Be an Important Indicator of Response to Therapy

Researchers have reported new evidence bearing on their multi-year effort to identify clinically useful markers of high risk for the onset of psychosis in young people. Read More

Study: Following Cannabis Commercialization, Occasional Use in Those With Psychosis History Increased Much More Than in General Population, Posing Potential Risk

What impact has legalization and commercialization of recreational cannabis had on people with schizophrenia and other disorders involving psychosis? It’s an important question, particularly in view… Read More

In First-Episode Psychosis Patients, Machine Learning Predicted Illness Trajectories to Potentially Improve Outcomes

There is broad agreement among psychiatrists, based on many years of clinical experience, that early treatment following a first episode of psychosis (FEP) provides the best chance for improving a… Read More

A Way to Repair a “Leaky” Blood-Brain Barrier is Tested, Potentially Relevant for Schizophrenia, Autism and Other Disorders

A team of researchers co-led by a three-time BBRF grantee has developed a way to potentially repair the integrity of the blood-brain barrier (BBB), the protective membrane that separates the brain… Read More

Psychosis

TOPICS

Tags

ABOUT US

CONTACT US